Skip to main content
PMC home page
Diabetology & Metabolic Syndrome logoLink to Diabetology & Metabolic Syndrome
. 2022 Jul 15;14:98. doi: 10.1186/s13098-022-00866-1

Correction to: Insulin use in type 2 diabetic patients: a predictive of mortality in covid-19

Marc Assaad 1,✉, Nakisa Hekmat-Joo 1, Jef Hosry 1, Ali Kassem 1, Ahmad Itani 2, Loai Dahabra 1, Ahmad Abou Yassine 1, Julie Zaidan 3, Dany El Sayegh 2
PMCID: PMC9283813  PMID: 35841110

Correction to: Diabetology & Metabolic Syndrome (2022) 14:85 10.1186/s13098-022-00857-2

Following publication of the original article [1], the publisher identified an error in article title. The correct title is given below.

  • Insulin use in type 2 diabetic patients: a predictive of mortality in covid-19

The original article has been [1] revised.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Assaad M, Hekmat-Joo N, Hosry J, Kassem A, Itani A, Dahabra L, Abou Yassine A, Zaidan J, El Sayegh D. Insulin use in type 2 diabetic patients: a predictive of mortality in covid-19. Diabetol Metab Syndr. 2022;14:85. doi: 10.1186/s13098-022-00857-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Diabetology & Metabolic Syndrome are provided here courtesy of BMC

RESOURCES